Acute Pharyngitis Market Report 2026

Acute Pharyngitis Market Overview

• Acute Pharyngitis market size has reached to $2.89 billion in 2025 • Expected to grow to $4.25 billion in 2030 at a compound annual growth rate (CAGR) of 8% • Growth Driver: Impact Of Rising Influenza Cases On Throat Infections • Market Trend: Innovations In Syndromic Point-Of-Care (POC) Technology Enhance Rapid Detection And Diagnostic Accuracy In Acute Pharyngitis • North America was the largest region in 2025.

What Is Covered Under Acute Pharyngitis Market?

Acute pharyngitis is the inflammation of the pharynx, which is the part of the throat located behind the mouth and nasal cavity. This condition results in a sore throat and accompanied by symptoms such as fever, headache, and swollen lymph nodes. It can be caused by various infections, including viral, bacterial, and fungal, with viral infections being the most prevalent. The main treatments in the acute pharyngitis market are antibiotics, antivirals, over-the-counter (OTC) medications, corticosteroids and anti-inflammatory drugs, and alternative remedies. Antibiotics are medications that treat bacterial infections by either killing the bacteria or inhibiting their growth. The various distribution channels include hospital pharmacy, online pharmacy, and retail pharmacy, and several end-users including hospitals, homecare, specialty centers, and others.

What Is The Acute Pharyngitis Market Growth Forecast?

The acute pharyngitis market size is expected to see strong growth in the next few years. It will grow to $4.25 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to development of novel antivirals and antibiotics, increasing telemedicine adoption, growth of online pharmacy platforms, rising awareness of herbal and alternative remedies, expansion of homecare and specialty care services. Major trends in the forecast period include rising use of antibiotics and antivirals for acute pharyngitis, growing adoption of over-the-counter medications, increasing preference for herbal and alternative remedies, expansion of hospital and homecare treatment options, focus on anti-inflammatory and corticosteroid therapies.

Global Acute Pharyngitis Market Segmentation

1) By Treatment: Antibiotics, Antivirals, Over-the-Counter (OTC) Medications, Corticosteroids And Anti-inflammatory Drugs 2) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy 3) By End-User: Hospitals, Homecare, Speciality Centres, Other End Users Subsegments: 1) By Antibiotics: Penicillins, Cephalosporins, Macrolides 2) By Antivirals: Neuraminidase Inhibitors, Nucleoside Analogs 3) By Over-the-Counter (OTC) Medications: Analgesics, Throat Lozenges, Cough Syrups 4) By Corticosteroids And Anti-inflammatory Drugs: Glucocorticoids, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

What Are The Drivers Of The Acute Pharyngitis Market?

A rise in the prevalence of influenza is expected to propel the growth of the acute pharyngitis market going forward. Influenza is attributed to infection with influenza viruses, which spread through respiratory droplets from coughs, sneezes, or contact with contaminated surfaces. The rise in prevalence of influenza is due to factors such as seasonal variations, low vaccination rates, increased human mobility, viral mutations, and weakened immunity in certain populations. Acute pharyngitis treatment helps influenza patients by alleviating throat inflammation and pain, reducing discomfort while swallowing, preventing secondary bacterial infections, and supporting overall recovery, which, when combined with antiviral medications, adequate hydration, and rest, enhances the body's ability to fight the influenza virus more effectively. For instance, according to the Centers for Disease Control and Prevention, a US-based government agency, as of February 2025, the percentage of clinical lab tests that were positive for influenza reached 31.6%, up from 29.4% the previous week and 18.6% at the start of the year. Thus, the rise in prevalence of influenza is driving the growth of the acute pharyngitis industry. The high prevalence of respiratory infections is expected to drive the growth of the acute pharyngitis market in the coming years. Acute pharyngitis is an inflammation of the pharynx, commonly caused by viral or bacterial infections, leading to sore throat, fever, and difficulty swallowing. The increasing occurrence of respiratory infections, particularly in children and adults during seasonal outbreaks, is a major factor contributing to the rising demand for diagnosis and treatment of acute pharyngitis. For instance, in May 2025, according to the Centers for Disease Control and Prevention, a US-based government public health agency, chronic obstructive pulmonary disease (COPD) was reported as the fifth leading cause of death in the United States in 2023, resulting in 141,733 deaths. In the same year, the age-adjusted prevalence of diagnosed COPD in adults aged 18 years and older was 3.8 percent. Therefore, the high prevalence of respiratory infections is propelling the growth of the acute pharyngitis industry.

Key Players In The Global Acute Pharyngitis Market

Major companies operating in the acute pharyngitis market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, F. Hoffmann La Roche AG, Abbott Laboratories, Bayer AG, Eli Lilly and Company, Bristol Myers Squibb Company, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Hikma Pharmaceuticals PLC, Lupin Limited, Alkem Laboratories Ltd., Cipla Limited, Sun Pharmaceutical Industries Limited

Global Acute Pharyngitis Market Trends and Insights

Major companies operating in the acute pharyngitis market are focusing on developing advanced solutions, such as multiplex syndromic POC testing, to enhance diagnostic speed, improve accuracy, and support pathogen-specific treatment decisions. Multiplex POC testing refers to a technological approach that can detect multiple pathogens from a single sample in a short time, enabling clinicians to differentiate between viral and bacterial infections and reduce unnecessary antibiotic use. For instance, in June 2024, bioMérieux, a France-based medical equipment manufacturer, received FDA Special 510(k) clearance and a CLIA waiver for its BIOFIRE SPOTFIRE Respiratory/Sore Throat Panel Mini, which identifies common viral causes of sore throat as well as Group A Streptococcus from a single throat or nasopharyngeal swab in approximately 15 minutes. The test runs on the BIOFIRE SPOTFIRE platform, allowing clinicians to choose a small or larger multiplex respiratory panel depending on need and setting. The Mini panel demonstrates strong sensitivity for four respiratory viruses, including rhinovirus and influenza, and for Streptococcus A, helping clinicians make rapid, targeted treatment decisions.

Regional Outlook

North America was the largest region in the acute pharyngitis market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Acute Pharyngitis Market?

The acute pharyngitis market consists of revenues earned by entities by providing services such as diagnostic testing services, pharmaceutical dispensing services, and preventive and vaccination services. The market value includes the value of related goods sold by the service provider or included within the service offering. The acute pharyngitis market also includes sales of penicillin, amoxicillin, azithromycin, throat gargles and rinses. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Acute Pharyngitis Market Report 2026?

The acute pharyngitis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the acute pharyngitis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.